Sanofi (NASDAQ:SNY) intends to commence a tender offer to acquire all of the outstanding common shares of Principia Biopharma for $100/share in cash, representing equity value of ~$3.68B.
The offer is scheduled to expire on September 25.
The company agreed to buy Principia Bio earlier in August.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.